Pde11a Rat Pre-designed siRNA Set A contains three designed siRNAs for Pde11a gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control. Components Pde11a siRNA-1: 5 nmol (HPLC) Pde11a siRNA-2: 5 nmol (HPLC) Pde11a siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)
Especificações
Condições de armazenamento de armazenamento
Store at -20°C
Enviado em
Ice chest + Ice pads
Este produto requer transporte de cadeia fria. Serviços terrestres e outros serviços econômicos não estão disponíveis.
Product Line
Produtos biológicos
Dados avançados
Certificados(CoA,COO,BSE/TSE e Mapa de Análise)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calculadoras de soluções
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Revisões
Avaliações dos Clientes
Application Protocols
Item-specific tested applications, recommended dilutions, and controls: Not specified for this item; refer to CoA/Spec Sheet.
Workflow: reconstitute in RNase-free solvent, prepare working dilutions, form complexes with a validated transfection reagent in serum-free medium, incubate with cells, then replace/overlay with complete medium as specified by the transfection reagent.
Controls: include non-targeting siRNA and, if available, a positive control siRNA.
Readouts: quantify knockdown by RT-qPCR (mRNA) and/or immunoassay (protein). Validate on-target effects and check for cytotoxicity.
Note: Follow your transfection reagent manufacturer’s protocol. The above is general practice and not a substitute for item-specific instructions.
Biological Roles
Item-specific biological details: The product name indicates targeting of rat Pde11a. No further item-specific target annotations are provided.
Literature context (for the target gene):
PDE11A (phosphodiesterase 11A) is a dual-specificity cyclic nucleotide phosphodiesterase that hydrolyzes cAMP and cGMP, modulating intracellular signaling. Multiple isoforms arise from alternative splicing, with tissue-dependent expression patterns reported in mammals.
Functional implications: by regulating cyclic nucleotide pools, PDE11A influences downstream effectors such as PKA/PKG and associated signaling modules. Perturbation can affect pathways linked to metabolism, signaling dynamics, and transcriptional responses, depending on cell type and isoform.
Experimental use of siRNA against Pde11a allows interrogation of pathway dependence and compensation by other PDE family members in rat systems. Researchers typically confirm target knockdown at mRNA and protein levels and assess functional readouts tied to cyclic nucleotide signaling.
Note: The above roles are literature-derived for context and are not product specifications. This product is for research use only.
Buffer Applications
Not typically applicable. This product is an siRNA reagent, not a buffering agent.
General/literature guidance related to siRNA handling:
Reconstitution buffers: RNase-free water for immediate use; RNase-free 1× TE (pH 7.5–8.0) can enhance storage stability. Avoid Mg2+/Mn2+ in stock solutions unless protocol-specific.
Working solutions: dilute into serum-free medium for complex formation with transfection reagents, then add to complete medium per reagent guidance.
Item-specific buffer composition: Not specified for this item; refer to CoA/Spec Sheet.
Green Alternatives
Applicability: siRNA workflows are predominantly aqueous and already align with several green chemistry principles.
General sustainability considerations (literature):
Solvent choice: use RNase-free water or buffered saline/TE instead of organic solvents wherever possible. Complexation and delivery are typically performed in serum-free medium, minimizing volatile organic compound (VOC) use.
Resource efficiency: prepare concentrated stocks and aliquot to reduce waste from repeated freeze–thaw. Thaw on ice to avoid degradation-related repeat syntheses.
Waste minimization: plan transfections to scale to analytical needs, reducing excess reagent and consumables.
Alternative delivery methods: select transfection methods that operate efficiently at lower siRNA doses to reduce material input and downstream waste.
Trade-offs:
Some high-efficiency delivery reagents contain surfactants or polymers with non-trivial environmental footprints. Where feasible, select formulations with lower cytotoxicity and improved biodegradability, while maintaining performance.
Item-specific greener options: Not specified for this item; refer to CoA/Spec Sheet.
Pharmaceutical Uses
Not applicable for this catalog item. The Product Data specifies: For research use only.
General note: siRNA technologies are studied broadly in formulation science (e.g., lipid nanoparticles, conjugates), but such development is beyond the scope of this research reagent listing. No pharmacopeial status, excipient role, or clinical use is claimed or implied for this item.
Physical Properties
Item-specific properties: Not specified for this item; refer to CoA/Spec Sheet.
General/literature characteristics for siRNA reagents (for context, not product specifications):
Physical state: typically supplied lyophilized or in aqueous buffer; polyanionic oligonucleotide.
Solubility: readily soluble in RNase-free water and common biological buffers (e.g., 1× TE, PBS) at research-use concentrations.
pKa/logP: not applicable in the conventional small-molecule sense due to polyanionic, macromolecular character; behaves as a highly charged hydrophile.
Stability: siRNA duplexes are sensitive to nucleases; stability depends on sequence and any chemical modifications (not specified for this item). Lyophilized material is generally stable at −20 °C protected from moisture; aqueous solutions are more labile and benefit from low-temperature storage and RNase-free conditions.
UV properties (literature): RNA absorbs at ~260 nm; concentration is often estimated using A260 (ε depends on sequence and length; not specified for this item).
Quality and Grades
Item-specific grade, purity, and stabilizers: Not specified for this item; refer to CoA/Spec Sheet.
General context for siRNA reagent quality (literature/industry practice):
Oligonucleotide quality can vary (e.g., desalted, cartridge-purified, HPLC- or PAGE-purified). Higher-purity siRNAs typically yield more consistent knockdown and lower off-target effects.
Modifications (2'-O-Me, 2'-F, phosphorothioates, terminal conjugates) may be used to enhance stability or delivery; none are specified for this item.
“Pre-designed” sets usually indicate bioinformatic selection of multiple sequences targeting distinct regions to enable empirical selection of the most effective duplex in the end-user system.
Recommended verification: end users often validate knockdown via RT-qPCR or Western blot. Sequence identity, length, and purity specifications—when provided—are found on the vendor CoA.
What is specific here: the product name indicates a Rat Pde11a Pre-designed siRNA Set A; however, no explicit grade or purification level is listed in the provided data.
Reaction and Applications
Item-specific application notes: Not specified for this item; refer to CoA/Spec Sheet.
General/literature applications relevant to this product type:
RNA interference (RNAi): transient knockdown of rat Pde11a transcript in cell culture or ex vivo models to study pathway dependence and phenotype. Use multiple duplexes from Set A to identify the most effective sequence.
Assay endpoints: mRNA reduction by RT-qPCR, protein reduction by immunoblotting or immunoassays. Functional readouts may include changes in cyclic nucleotide signaling consistent with PDE11A biology (see Biological Roles section).
Delivery: lipid-mediated transfection (e.g., cationic lipids), polymer-based reagents, or electroporation. Optimize conditions per cell type and transfection reagent.
Controls: include a non-targeting siRNA negative control and, when possible, a positive control siRNA targeting a known gene to benchmark transfection efficiency.
Off-target minimization: test multiple sequences, use minimal effective dose, and maintain appropriate exposure time to reduce compensatory effects and cytotoxicity.
Note: No item-specific sequences, modifications, or validation data are provided in the Product Data; practical details above are general guidance for siRNA use.
Reaction Conditions
Not applicable to chemical reaction conditions. This product is not used in classical organic reactions.
General/literature operational conditions for siRNA transfection (for context only; not item-specific protocols):
Temperature: standard mammalian cell culture conditions (typically 37 °C, 5% CO2).
Medium: sequence complexation often in serum-free medium (e.g., Opti-MEM), then added to complete medium after complex formation per transfection reagent guidelines.
Timing: knockdown assessment commonly at 24–72 h post-transfection for mRNA; 48–96 h for protein, depending on turnover.
Dosing: typical screening ranges are in the low to mid-nanomolar final concentration; optimize to minimize off-target effects and cytotoxicity.
Item-specific conditions: Not specified for this item; refer to CoA/Spec Sheet and the chosen transfection reagent’s instructions.
Safety and Handling
Item-specific hazard classification: Not specified for this item; refer to SDS.
General handling guidance for nucleic acid reagents (literature/typical practice):
PPE: laboratory coat, gloves, and eye protection. Use RNase-free technique to prevent degradation (RNase-free tubes, tips, and buffers).
Engineering controls: work in a clean area; a biosafety cabinet is recommended if handling cell culture or transfection mixtures.
Incompatibilities: avoid RNase contamination (skin contact, shared reagents). Strong acids/bases and nucleases will degrade RNA. Avoid repeated freeze–thaw cycles.
First aid (overview): in case of contact with eyes/skin, rinse with water. If inhaled (powder), move to fresh air. If ingested, rinse mouth. Seek medical attention if symptoms persist. Defer to SDS for authoritative instructions.
Waste: dispose of according to institutional guidelines for non-hazardous biological/chemical waste unless local rules specify otherwise.
Transportation and thermal sensitivity: supplied for shipment on cold packs to maintain integrity; do not allow prolonged exposure to elevated temperatures.
Solvent Selection
Item-specific solvent recommendations: Not specified for this item; refer to CoA/Spec Sheet.
General guidance for siRNA (literature):
Primary solvent: RNase-free water for initial reconstitution. For longer-term stability, RNase-free 1× TE (10 mM Tris, 1 mM EDTA, pH 7.5–8.0) is commonly used to chelate trace metal ions that catalyze degradation.
Compatibility: aqueous buffers (PBS, Opti-MEM for complexation during transfection) are typical. Avoid organic solvents that may denature or precipitate RNA.
Concentration planning: prepare an intermediate stock (e.g., 10–20 µM) to minimize freeze–thaw; aliquot into single-use volumes.
When to choose alternatives: if using lipid-based transfection reagents, follow the reagent’s recommended diluent (often serum-free medium) during complex formation.
Comparison (literature):
RNase-free water vs 1× TE: water maximizes versatility for downstream complexation; TE improves storage stability but EDTA can chelate divalent cations in some protocols. Choose based on the immediate application.
Storage and Reconstitution
Item-specific storage and shipping:
Storage Conditions: Store at −20 °C (from Product Data).
Item-specific reconstitution instructions: Not specified for this item; refer to CoA/Spec Sheet.
General/literature guidance for siRNA handling (for context):
Upon receipt: allow shipping container to equilibrate briefly to prevent condensation, then transfer vials to −20 °C. Avoid repeated freeze–thaw; aliquot after first reconstitution.
Reconstitution: add RNase-free water or RNase-free 1× TE to the desired stock concentration (commonly 10–20 µM in oligo terms). Mix gently; do not vortex vigorously. Spin down briefly to collect contents.
Storage after reconstitution: store aliquots at −20 °C (short-to-mid term). For extended storage, −80 °C is commonly used. Protect from light and moisture. Maintain RNase-free technique throughout.
Thawing: thaw on ice; keep on cold block during setup. Discard aliquots that have undergone multiple freeze–thaw cycles.
Research use only.
Structure and Identity
Item-specific identifiers: Not specified for this item; refer to CoA/Spec Sheet.
Molecular formula (item-specific): Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight (item-specific): Not specified for this item; refer to CoA/Spec Sheet.
SMILES / InChI / InChIKey: Not applicable for complex oligonucleotide mixtures; not specified for this item.
General/literature description (siRNA):
This product is described as a pre-designed siRNA Set A targeting rat Pde11a (phosphodiesterase 11A). siRNA reagents are typically double-stranded RNA oligonucleotides (~19–27 base pairs) with 2-nt 3' overhangs.
Structural features (literature): a sense and an antisense RNA strand, phosphodiester backbone (often with optional phosphorothioate linkages or base/sugar modifications in some products), multiple anionic phosphate groups, and ribose sugars (2'-OH). Set A commonly denotes a small panel of distinct duplexes targeting non-overlapping regions of the same transcript to enable screening (nomenclature varies by vendor).
Synthetic Utility
Not applicable in the traditional organic synthesis sense. This product is a functional nucleic acid (siRNA) intended for gene silencing experiments, not as a small-molecule building block or reagent.
General/literature note:
siRNA duplexes do not participate as reagents in standard chemical transformations (e.g., cross-coupling, oxidations). Their “utility” is biological: transiently reducing target gene expression via RISC-mediated mRNA cleavage.
For chemical synthesis of oligonucleotides, phosphoramidite coupling chemistry on solid support is typical, followed by deprotection and purification; however, no synthesis route, modification pattern, or purity level is provided for this item.
Target Specificity
Item-specific information from Product Data:
Target: Rat Pde11a (phosphodiesterase 11A) — indicated by the product name.
Format: Pre-designed siRNA Set A — implies multiple siRNA duplexes targeting Pde11a (exact number, sequences, and modification status are not specified for this item).
No additional specificity data (e.g., sequences, isoform selectivity, off-target screening, cross-species reactivity) are provided in the Product Data. Consult the CoA/Spec Sheet for sequence-level details if available.
Perguntas frequentes
How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.
Usamos cookies para garantir o funcionamento adequado do site e, quando permitido, para melhorar a sua experiência. Você pode gerenciar suas preferências a qualquer momento nas Configurações. Saiba mais em nossa Política de Cookies.
Deseja que lhe enviemos uma mensagem quando tivermos descontos disponíveis?
Lembrar-me mais tarde
Obrigado! Por favor, verifique a sua caixa de entrada de e-mail para confirmar.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.